AIC
SLNO

AWM Investment Company’s Soleno Therapeutics SLNO Stock Holding History

AWM Investment Company’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,000
Closed -$926K – 111
2025
Q4 		$926K Buy
+20,000
New +$1.1M 0.09% 96
2024
Q1 		– Sell
-20,000
Closed -$805K – 123
2023
Q4 		$805K Buy
+20,000
New +$569K 0.11% 94
2021
Q2 		– Sell
-33,456
Closed -$632K – 125
2021
Q1 		$632K Sell
33,456
-69,877
-68% -$2.25M 0.07% 105
2020
Q4 		$2.99M Hold
103,333
– – 0.38% 67
2020
Q3 		$3.89M Hold
103,333
– – 0.64% 51
2020
Q2 		$3.44M Buy
+103,333
New +$4.48M 0.6% 48

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

AWM Investment Company's SLNO Position: Q1 2026 in Review

AWM Investment Company sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 20,000 shares — an estimated $926K sold.

AWM Investment Company first reported a position in SLNO in Q2 2020 and held it in 6 quarters. The position peaked at $3.89M in Q3 2020. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • AWM Investment Company reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AWM Investment Company sold 20,000 Soleno Therapeutics shares in Q1 2026, an estimated $926K.
  • AWM Investment Company first reported a position in Soleno Therapeutics in Q2 2020 and held it in 6 quarters.
  • AWM Investment Company's Soleno Therapeutics position peaked at $3.89M in Q3 2020.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.